$Regulus Therapeutics(RGLS.US)$Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose (Mad) Clinical Trial of Rgls8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (Adpkd)
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity. The biopharmaceutical industry is a rapidly evolving space, with companies constantly seeking funds to fuel their innovative efforts. One such company making headlines is Regulus Therapeutics Inc. (NASDAQ: RGLS). The San Diego-based company recently announced an oversubscribed private placement of equity, raising a remarkable $100 million.$Regulus Therapeutics(RGLS.US)$ ...
Regulus Therapeutics股票讨论区
Good premium - Buy and trade sell put options to earn option premium...weekly
The biopharmaceutical industry is a rapidly evolving space, with companies constantly seeking funds to fuel their innovative efforts. One such company making headlines is Regulus Therapeutics Inc. (NASDAQ: RGLS). The San Diego-based company recently announced an oversubscribed private placement of equity, raising a remarkable $100 million. $Regulus Therapeutics(RGLS.US)$
...
暂无评论